1. Successful administration of a low dose of calcium nadroparin in patients suffering from pulmonary embolism and brain metastases: a report of two cases.
Vitale FV, Rotondo S, Sessa E, Antonelli G, Colina P, Parisi A, Giamo V, Ferraù F.
J Oncol Pharm Pract. 2009 Dec 16. [Epub ahead of print]
2. The effect of LMWH (Nadroparin) on tumor progression.
Nagy Z, Turcsik V, Blaskó G.
Pathol Oncol Res. 2009 Dec;15(4):689-92.
3. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
и т. д. и т. п.